Dr. Yozwiak serves as the Head of Research at the Gene and Cell Therapy Institute (GCTI) of Mass General Brigham, a translational medicine institute affiliated with Mass General Hospital and Brigham and Women’s Hospital. At the GCTI, he is overseeing and supporting a large group in investigators, whose mission is to bridge early-stage discovery research in the gene and cell therapy space with patient populations. He supports a wide range of gene and cell therapy research programs at Mass General Brigham, and will provide direct guidance for this project on viral vector applications and experimental design.
Dr. Yozwiak is a scientific leader with 20+ years’ experience in virology research, broadly focused on using genomics to investigate viruses for gene therapy and to understand human disease. Prior to Mass General Brigham, he was the founding Director of Viral Genomics at Ring Therapeutics, a Flagship Pioneering-backed biotech startup, where his work uncovering commensal viruses as a novel gene delivery platform enabled fund raising of $204M in three years.
Previously, he was Associate Director of Viral Genomics at the Broad Institute of Harvard and MIT and an Associate of the Department of Organismic and Evolutionary Biology at Harvard University. He managed research projects studying virus diagnostics and evolution in collaboration with partners in West Africa and helped establish the African Center of Excellence for Genomics of Infectious Disease (ACEGID; acegid.org) at Redeemer's University, Nigeria, where he was an Adjunct Senior Lecturer in the Department of Biological Sciences.
